Using a web app to improve hormone therapy adherence in breast cancer patients
Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer
This study tests if a web app can help breast cancer patients stick to their hormone therapy and feel better during treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 438 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Centre Francois Baclesse Academic / other |
| Locations | 1 site (Caen) |
| Trial ID | NCT04554927 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a web application designed to support patients undergoing adjuvant hormone therapy for breast cancer. The hypothesis is that this digital tool will enhance treatment adherence and improve the quality of life for patients compared to standard management practices. Participants will be monitored over 18 months to assess their compliance with the therapy and overall well-being. The study aims to provide insights into how technology can aid in cancer treatment management.
Who should consider this trial
Good fit: Ideal candidates are French-speaking adults over 18 years old who are starting adjuvant hormone therapy for breast cancer and have access to a smartphone or computer.
Not a fit: Patients who have previously received hormone therapy for cancer or those with significant medical or psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve adherence to hormone therapy, leading to better health outcomes for breast cancer patients.
How similar studies have performed: While the use of digital tools in healthcare is growing, this specific approach to enhancing hormone therapy adherence in breast cancer patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient \> 18 years old * Breast cancer patient candidate for adjuvant hormone therapy * Mastery of the French language * Patient with a cell phone and an Internet connection * Patient able to use a computer, smartphone, or tablet. * Patient affiliated to a social security system * Signing of informed consent prior to any specific study-related procedure Exclusion Criteria: * Patient who has previously received hormone therapy for cancer. * Patient not trained in the use of the application * Any associated medical or psychiatric condition that might compromise the patient's ability to participate in the study * Patients with locoregional or metastatic recurrence * Other history of cancer. * Patient deprived of liberty, under guardianship or curatorship * Simultaneous participation in a therapeutic clinical trial or other clinical study involving a connected tool * Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons
Where this trial is running
Caen
- Centre François baclesse — Caen, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.